Cinnamide and hydrocinnamide derivatives with kinase inhibitory activity
US7652041B2 · kind B2 · utility
1Cited by
10References
39Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 12, 2006 |
| Grant date | Jan 26, 2010 |
| Priority date | — |
| Expiry date | Aug 11, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides novel cinnamide compounds useful as inhibitors of protein kinases. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.